Sort   by:  
 Page size 
UnknownPARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers.
Not available
S-EPMC9296104 | biostudies-literature
UnknownSelective CDK4/6 Inhibitors: Biologic Outcomes, Determinants of Sensitivity, Mechanisms of Resistance, Combinatorial Approaches, and Pharmacodynamic Biomarkers.
Not available
S-EPMC7306922 | biostudies-literature
UnknownEstrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion.
Not available
S-EPMC4934046 | biostudies-literature
UnknownLow molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.
Not available
S-EPMC2888821 | biostudies-literature
UnknownDifferential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells.
Not available
S-EPMC105379 | biostudies-literature
UnknownThe serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.
Not available
S-EPMC4362782 | biostudies-literature
UnknownLow-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.
Not available
S-EPMC6168358 | biostudies-literature
UnknownCyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.
Not available
S-EPMC2946214 | biostudies-literature
UnknownSpecific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer.
Not available
S-EPMC7078276 | biostudies-literature
UnknownStaurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner.
Not available
S-EPMC3786379 | biostudies-literature
Sort   by:  
 Page size